Ocular morbidity associated with intravitreal triamcinolone acetonide

Eye

Volumn 21, Issue 3, 2007, Pages 317-320

  Konstantopoulos, A ^a   Williams, C P R ^a   Newsom, R S ^a   Luff, A J ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIGLAUCOMA AGENT; CHLORAMPHENICOL; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CASE STUDY; CATARACT EXTRACTION; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DRUG INDICATION; ENDOPHTHALMITIS; EYE DISEASE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; PEROPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; RETINA DETACHMENT; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; SIDE EFFECT; TERTIARY HEALTH CARE; TRABECULECTOMY; TREATMENT DURATION; VITRECTOMY;

EID: 33847677203     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702416     Document Type: Article

References (22)

1. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular oedema. Arch Ophthalmol 2003; 121: 57-61.
2. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA et al. Intravitreal triamcinolone for treatment of macular oedema associated with central retinal vein occlusion. Arch Ophthalmol 2004; 122: 1131-1136.
3. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003; 87: 462-468.
4. Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology 2005; 112: 1916-1921.
5. Chan CCK, Paine M, O'Day J. Steroid management in giant cell arteritis. Br J Ophthalmol 2001; 85: 1061-1064.
6. McCluskey PJ, Towler HM, Lightman S. Management of chronic uveitis. BMJ 2000; 320: 555-558.
7. Ebner R, Devoto MH, Weil D, Bordaberry M, Mir C, Martinez H et al. Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone. Br J Ophthalmol 2004; 88: 1380-1386.
8. Hood PP, Cotter TP, Costello JF, Sampson AP. Effect of intravenous corticosteroid on ex-vivo leukotriene generation by blood leucocytes of normal and asthmatic patients. Thorax 1999; 54: 1075-1082.
9. Compton MM, Cidlowski JA. Rapid in vivo effects of glucocorticoids on the integrity of rat lymphocyte genomic deoxyribonucleic acid. Endocrinology 1986; 118: 38-45.
10. de Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan Jr E. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155-1159.
11. Brooks Jr HL, Caballero Jr S, Newell CK, Steinmetz RL, Watson D, Segol MS et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular oedema before and after intraocular injection of triamcinolone. Arch Ophthalmol 2004; 122: 1801-1808.
12. Stanbury RM, Graham EM. Systemic corticosteroid therapy - side effects and their management. Br J Ophthalmol 1998; 82: 704-708.
13. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24-27.
14. Gillies MC, Kuzniarz M, Craig J, Ball M, Luo W, Simpson JM. Intravitreal triamcinolone induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology 2005; 112: 139-143.
15. Moshfeghi DM, Kaiser PK, Bakri SJ, Kaiser RS, Maturi RK, Sears JE et al. Presumed sterile endophthalmitis following intravitreal triamcinolone acetonide injection. Ophthalmic Surg Lasers Imag 2005; 36: 24-29.
16. Moshfeghi DM, Kaiser PK, Scott IU, Sears JE, Benz M, Sinesterra JP et al. Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2003; 136: 791-796.
17. Ciardella AP, Klancnik J, Schiff W, Barile G, Langton K, Chang S. Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: An optical coherence tomography study. Br J Ophthalmol 2004; 88: 1131-1136.
18. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol 2005; 40: 63-68.
19. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kammppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonicle injection. Ophthalmology 2005; 112: 593-598.
20. Westfall AC, Osborn A, Kuhl D, Benz MS, Mieler WF, Holz ER. Acute endophthalmitis incidence: Intravitreal triamcinolone. Arch Ophthalmol 2005; 123: 1075-1077.
21. Michels RG, Wilkinson CP, Rice TA. Other causes of retinal detachment. In: Michels RG, Wilkinson CP, Rice TA (eds). Retinal Detachment. St Louis: The C.V Mosby Company, 1990, Chapter 4, pp 194-195.
22. Lim JI, Wolitz RA, Dowling AH, Bloom HR, Irvine AR, Schwartz DM. Visual and anatomical outcomes associated with postenor segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1999; 127: 288-293.